Maintain pressure on reforms to protect NHSVaccine shown to be effective against high blood pressure
The vaccine, called CYT006-AngQb and based on a virus-like particle, immunises against the effects of the chemical angiotensin II.
Angiotensin II is a blood chemical that causes vasoconstriction and increased blood pressure.
In the 14-week trial, 72 patients were randomly selected to either receive a placebo, or injected with either 100ug or 300ug doses of the vaccine in weeks 0, four and 12.
In the 300 ug group, there was a reduction in of 9.0 and 4.0 mm/Hg for mean ambulatory systolic and diastolic blood pressure compared with placebo.
It also reduced the early morning blood pressure surge by 13mm/Hg compared with placebo.
Lancet (2008) 371: 821-827
Online training units, written and reviewed by experts. Earn two hours' CPD and a personalised certificate for your portfolio.
Subscribers get five FREE learning units and non-subscribers can access each learning unit for £10 + VAT.
Share
Have your say
You must sign in to make a comment.